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Abstract 
 
Background: Increasing antibiotic resistance among human pathogenic microorganisms and the failure of 
conventional cancer therapies attracting great attention among scientists in the field of herbal medicine to develop 
natural antimicrobial and anticancer drugs. Thus, the antimicrobial and anticancer activities from fruits of the medicinal 
plant Urginea maritima (L.) Baker that unexplored previously were investigated in this study.  
Materials and Methods: Fruits of U. maritima plant were collected, dried, ground, and extracted by hot water, 
ethanol, methanol, and acetone. The fruit extracts were examined for their potential as antimicrobial and anticancer 
agents using the agar well diffusion method and MTT assay, respectively. The gene expression of some cancer-related 
gene markers was determined by RT-PCR. 
Results: All fruit extracts of U. maritima exhibited antibacterial activity against S. aureus and E. coli. Methanol and 
ethanol extracts exhibited anticandidal activity. Ethanol and acetone extracts displayed non-hemolytic activity and 
selective cytotoxicity against breast cancer MCF7 cells with IC50 values that considered as active treatments. 
Concerning DNA fragmentation and gene expression after treatment of MCF7 cells with the most promising acetone 
extract, induction of apoptosis was proposed. The expression of cancer-related gene TNF after 6 hours, tumor 
suppressor genes (p53 and BRCA1), and immune response genes (IL-2 and IL-6) was induced. The expression of anti-
apoptotic gene Bcl2 in treated MCF7 cells was reduced. 
Conclusion: Fruit extracts of U. maritima exhibited antimicrobial and anticancer activities. This result may lead to the 
use of these extracts for treatment of some infectious diseases and certain types of cancer. 
 
Keywords: Urginea maritime; antibacterial; antifungal; anticancer; gene expression 
 
Abbreviations: ATCC, American type culture collection; Bcl2, B-cell lymphoma 2; BRCA, Breast Cancer; GAPDH, 
Glyceraldehyde-3-phosphate dehydrogenase; IL, Interleukin; MCF7, Michigan cancer foundation-7; TNF, Tumor 
necrosis factor. 
 
Introduction 
 
Increasing antibiotic resistance among human pathogenic bacteria and fungi is becoming a serious challenge 
and a cause for global concern. Emergence of multidrug-resistant pathogenic strains of bacteria and fungi has caused a 
high rate of morbidity and mortality among patients. Therefore, there is a need to explore new sources for discovering 
novel classes of active secondary metabolites that have biological activities against multidrug-resistant bacteria and 
fungi. Therefore, the potential antimicrobial activities of extracts derived from plant origin were investigated in the 
current study.  
Cancer is a serious problem and a life-threatening illness. Cancer cells grow and spread without control 
throughout the body. Metastasis of cancer cells is considered as the major cause of cancer related mortality (DeSantis et 
al., 2011). New diagnosed cases are expected to rise by about 70% over the next two decades to reach twenty-two 
million cases (WHO, 2012). Cancer is considered as the second leading cause of death after cardiovascular disease 
worldwide (Turgay et al., 2005). In Jordan, cancer is the second most frequent cause of death after heart disease. It is 
the cause of death of more than 10,000 Jordanians from 1996 till now (Ministry of Health, Jordan Cancer Registry, 
2013). Enormous efforts are invested to cope with cancer problem, but limited success has been achieved with most of 
the therapeutic strategies (Abu-Dahab and Afifi, 2007). Therefore, one of the current trend in cancer therapy is to find a 
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cure from natural resources. Recently, there are various conventional therapies to fight cancer, including surgery, 
chemotherapy, immunotherapy, and radiotherapy (American Cancer Society, 2016). Unfortunately, there are some 
considerable limitations to use them due to the efficiency, availability, high cost, and its undesired side effects (Xu et 
al., 2009). Moreover, many cancer treatment protocols lack safety (Rebecca, 2004). Thus, there is an urgent need to 
find a safe and active anticancer agent. Three groups of genes; proto-oncogenes, tumor suppressor genes, DNA repair 
and immune enhancing genes (Schneider, 2012) control cancer cells. The study of these genes when using anticancer 
drugs, which up-regulate or down-regulate cell-controlling genes, has become very important to determine the 
mechanism of killing in cancer cells.  
The efforts in this study are oriented with hope toward finding new antimicrobial and anticancer agents from 
extracts of plant origin. Nature provides us with many products classified as secondary metabolites that originate from 
plants and have been used since ancient times to find new treatments to cancer. Therefore, this study is initiated to 
explore the potential anticancer activity of the selected medicinal plant Urginea maritima (L.) Baker (sea squill). The 
plant U. maritima is classified as a herb of the Liliaceae family and it is indigenous to the Mediterranean region 
including Jordan (Bozcuk et al., 2011). It has been well-known as a medicinal herb since early times, this plant is 
known to exert diuretic, cardiotonic properties, treat edema and has been used as a cough syrup (Bozcuk et al., 2011). 
On the other hand, the medicinal and poisonous activities of this plant refer to the presence of active phytochemicals. 
Analyses of U. maritima lead to the identification of many active compounds, such as cardiac steroids, anthocyanins, 
flavonoids, polysaccharides, and calcium oxalate (Al-Tardeh et al., 2006). Conversely, the acute toxicity of these 
compounds have been an evidence concerning the efficiency and possession of this to target and attack cancer cells 
(Mijatovic et al., 2007). Furthermore, in vitro and in vivo epidemiological data suggested that U. maritima derived 
cardiac steroids mediated anticancer activities through a regulated number of cellular processes such as proliferation, 
apoptosis and cell cycle arrest in various types of cancer cell lines including human leukemia, breast cancer cells 
(MCF7 and MDA-MB2311), prostate, melanoma, pancreatic, lung, and colon cancer cells (Daniela et al., 2003). It was 
reported that the bulb and leaf extracts of U. maritima have some potential antifungal activity (Abou-Jawdah et al., 
2004; Khan and Abourashed, 2010). However, the antimicrobial and anticancer biological activities of this medicinal 
plant are still largely unexplored. A literature survey on the U. maritima species indicates that no previous study that 
examines the antimicrobial and anticancer activities of extracts from fruits of U. maritima.  
In this study, screening of U. maritima fruit extracts was conducted against two test bacteria (Staphylococcus 
aureus and Escherichia coli), one fungus (Candida albicans), and breast cancer MCF7 cells to determine the 
antimicrobial and anticancer activities of fruit extracts, and to study the gene expression of some cancer related gene 
markers including tumor suppressor genes (p53 and BRCA1), antitumoral gene (TNF), anti-apoptotic gene (Bcl2), and 
immune response genes (IL-2 and IL-6) by reveres transcription-polymerase chain reaction (RT-PCR).  
 
Materials and Methods 
Plant collection 
 
The plant U. maritima was collected in March 2014 from Princess Tasneem bint Ghazi Technological 
Research Station in Al-Salt (Jordan), with coordinates: 32°05'N 35°40'E. The collected plant was identified by a 
taxonomist specialist Mr. Refad Khawaldeh at Jordan Royal Botanical Garden where a voucher specimen (Sharab 
073/2014) is conserved for future reference. 
 
Preparation of plant extracts 
 
The fruits of U. maritima was collected and washed with distilled water, dried at room temperature and then 
grind using blender. Each 10 g powdered plant material was extracted by refluxing with 100 ml of different solvents 
(hot water, ethanol, methanol, and acetone) for two weeks at room temperature with shaking at 150 rpm. All samples 
were filtered through white cheesecloth paper and Whitman filter papers, size 11.0 cm. Thereafter, solvents were 
evaporated until dryness at room temperature. The crude extracts were dissolved in 0.05% dimethyl sulphoxide 
(DMSO) to a final stock concentration of 30 mg/ml. All extracts were purified by filtration through 0.22 m filter units 
and kept at -20 °C until use. 
 
Antimicrobial activity 
 
Three test microorganisms, including; Staphylococcus aureus ATCC 25923 (Gram-positive bacterium), 
Escherichia coli ATCC 25922 (Gram-negative bacterium), and Candida albicans ATCC 10231 (Fungus) were used in 
this study. 
Test bacteria and test fungus were grown in nutrient broth (NB) at 37°C for 24 h and in sabouraund dextrose 
broth (SDB) at 28°C for 48 h, respectively. Bacterial and fungal cultures were serially diluted and adjusted to achieve 
2x10
6 
colony forming units (CFU/ml) for bacteria and 2x10
5 
spore/ml for fungi (Ceylan et al., 2008). 
The antibacterial activity of plant extracts was screened in triplicates against test bacteria by using the agar 
well diffusion according to the method of Perez et al. (1990) using nutrient agar (NA) plates and incubation at 37°C for 
24 h. The antifungal activity of plant extracts was performed in triplicates against test fungus in the same manner as 
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described for bacteria but by using sabouraund dextrose agar (SDA) plates and incubation at 28°C for 48 h. The 
antimicrobial activity was evaluated by measuring the inhibition zone diameter in mm around the wells. 
 
Hemolytic activity 
 
Human erythrocytes were freshly prepared and used to determine the hemolytic activity of U. maritima plant 
crude extracts. Hemolytic activity was tested on blood agar medium according to manufacturer's instructions (Oxoid, 
UK), supplemented with 5% normal human erythrocytes. A 50 µl of each crude extract was inoculated into each well 
(5 mm i.d.) prepared on blood agar plates. The type of hemolysis was determined after incubation of plates at 37°C for 
48 h (Carrillo et al., 1996). 
 
Mammalian cells and culture conditions 
 
Two mammalian cell lines, including; normal cells (MCF10A; non-tumorigenic human breast epithelial cell 
line) and cancer cells (MCF7; human breast adenocarcinoma cell line) were kindly supplied from Faculty of 
Medicine/University of Jordan and used in this study. The human breast cancer cell line MCF7 was used to investigate 
the anticancer activity of plant crude extracts. Whereas, MCF10A cells were used to determine the selectivity of 
anticancer activity produced against MCF7 cells. 
The adherent human breast cancer cell line MCF7 was grown in Dulbecco’s modified Eagle’s medium 
(DMEM), pH 7.4, supplemented with 10% feotal bovine serum (FBS), 40 µg/ml gentamicin, 50 µM 2-
mercaptoethanol, 10 mM N-2-hydroxyethylpiperzine-N-2-ethane sulfonic acid (HEPES), 1 mM sodium pyruvate, 100 
U/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine, and it was harvested at 70% confluence and 
subcultured every 48 h at 37
o
C in a humidified 5% CO2 incubator (Freshney, 2005). To harvest the adherent MCF7 
cells, growth medium was removed and cells were washed with PBS. To produce a cellular suspension, a cell 
dissociation solution made of trypsin-EDTA (1X) was added and incubated at 37
o
C for 5 min in a humidified 5% CO2 
incubator. Trypsinized cells were reseeded in fresh medium at 105 cells/ml and incubated at 37oC in a humidified 5% 
CO2 incubator.  
The adherent MCF10A cells were grown in DMEM/F12 media, pH 7.4, supplemented with 5% horse serum, 
20 ng/ml of epidermal growth factor (EGF), 10 µg/ml insulin, 100 µg/ml hydrocortisone, 10 ng/ml cholera toxin, 100 
U/ml penicillin, and 100 µg/ml streptomycin. The cells were harvested, trypsinized, and reseeded in the same manner 
as for MCF7 cells. 
 
Cytotoxicity screening assay 
 
For screening assay, 100 µl of each non-hemolytic U. maritima fruit crude extract (400 µg/ml constant 
concentration) was added in fresh DMEM medium, mixed thoroughly by pipetting and inoculated into adherent MCF7 
cells supplemented by new 100 µl medium and were loaded into each well of 96 well micro test plates. Cells were 
plated at a density 2x10
4
 cells/well, counted by hemocytometer. The cultures were incubated at 37
o
C in a humidified 
5% CO2 incubator for 72 h. At the end of incubation time, the viability of cells was assessed by 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H tetrazolium bromide (MTT) assay (Heiss et al., 1997). 
To determine the selectivity of cytotoxicity (killing cancerous cells specifically), the cytotoxic U. maritima 
plant crude extract was performed in the same manner for normal MCF10A cells but using DMEM/F12 medium.  
 
In vitro cytotoxicity assay 
 
 To measure the level of cell viability, the MTT test method was used according to Pledgie-Tracy et al. (2007). 
Briefly, cells (MCF7 and MCF10A) were cultured in 96-well plates (2x10
4
 cells/well) containing 100 µl medium and 
were incubated at 37°C for 24 h in a humidified 5% CO2 atmosphere. After that, 100 µl fresh medium was added to the 
cells in the plates with another 100 µl medium containing different concentrations of U. maritima plant extracts (12.5, 
25, 50, 100, 200, and 400 µg/ml). The U. maritima fruit extracts were added in triplicates and incubated for another 72 
h. Cancer cells (untreated with extracts) were treated with different concentrations of the positive control Doxorubicin 
(12.5, 25, 50, 100, 200, and 400 µg/ml).  Diluted U. maritima fruit extracts were freshly prepared in DMEM medium 
prior to each experiment. The metabolic activity of each well was determined by the MTT assay and compared to those 
of untreated cells (negative control). Negative control (all vehicle components except plant extract) was run in 
triplicates parallel to each assay. At the end of incubation, media was removed from each well and MTT dye solution (5 
mg/ml) was dissolved in PBS and added as 20 µl/well in the plates. Plates were incubated at 37°C for 4 h in a 
humidified 5% CO2 atmosphere. After all, 100 µl of DMSO was added to each well, mixed thoroughly to dissolve the 
dye crystals, and immediately incubated at room temperature in the dark for 15 min. The absorbance was measured 
using microplate reader (TECAN, Austria) at 450 nm with a reference wavelength of 630 nm (Heiss et al., 1997). 
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Determination of median inhibitory concentration 
 
  The 50% inhibitory concentration (IC50) was determined by comparing the average of mortality values of six 
crude concentrations (12.5, 25, 50, 100, 200, and 400 µg/ml) with that produced from negative control as well as with 
results of the positive control Doxorubicin. The IC50 values, regression equations, and correlation coefficients (R
2
) were 
determined by using log-probit analysis (MS Excell, Microsoft Co., 2010). Each treatment was achieved in triplicate.  
 
Mechanism of action determination 
  
DNA fragmentation was performed according to Wang et al. (2004). MCF7 cells (2x10
6
 cells/well) were 
exposed to the IC50 of non-hemolytic U. maritima fruit extracts for 6 h and 24 h. After incubation, cells were washed 
with PBS buffer, harvested by 1X trypsin, and pelleted by centrifugation. Cell pellets were subsequently resuspended in 
600 µl of lysis buffer, and DNA was extracted using Promega Genomic DNA purification kit according to 
manufacturer's instructions (Promega, USA). Then 10 µl of DNA solution was transferred to 1.2% agarose gel and 
electrophoresis was carried out at 80 V for 2 h with 0.5X Tris-borate-EDTA (TBE) buffer as running buffer. DNA in 
the gel stained with ethiduim bromide was visualized under UV illuminator and the degree of apoptotic DNA 
fragmentation was determined by comparison with negative and positive controls. 
 
RNA Extraction 
 
The non-hemolytic extract from U. maritima fruits that exhibited a promising selective cytotoxicity with the 
best IC50 value was used to treat MCF7 cells separately for 6 and 24 h with the IC50 and the quadruple IC50. About 
5x10
6
 cells that were grown in DMEM medium at pH 7.4 and supplemented with 10% FBS were treated with plant 
extract in concentrations equivalent to IC50 and 4xIC50. The cells were washed with PBS buffer, harvested by using 1X 
trypsin, and then centrifuged to pellet cells. RNA was extracted from pellet cells using the RNA extraction Mini Kit 
according to manufacturer's instructions (Affymetrix, USA). Moreover, RNA was extracted from MCF7 treated with 
1xIC50 and 4xIC50 of Doxorubicin drug (Abcam, UK). On the other hand, RNA was extracted from untreated MCF7 
breast cancer cells (negative control) grown in DMEM and 10% FBS. The quality and quantity of total RNA was 
assessed by Nanodrop spectrophotometer (ND-1000, Thermo Fisher Scientific Inc., MA, USA) and the purity of the 
RNA was assessed by the ratio of A260/A280. RNA samples were kept at -80ºC until use. 
 
cDNA synthesis by reverse transcription PCR  
 
The RNA samples were reversely transcribed to their complementary DNA (cDNA). The RT reaction 
consisted of 1 μg of total RNA, oligo (dT) primer (Promega, USA), and Improm-II Reverse Transcriptase (Promega, 
USA) in a total volume of 20 μl according to manufactures' instructions using the thermocycler, lifePro PCR System 
(BIOER, China). A negative control using Diethylpyrocarbonate (DEPC) treated water without RNA sample was used 
to check if there was any contamination. After that, the cDNA samples were kept at -20ºC until use. The quality and 
quantity of total cDNA samples were assessed by Nanodrop spectrophotometer (ND-1000, Thermo Fisher Scientific 
Inc., MA, USA).  
 
Gene expression analysis 
 
The cDNA generated from RNA that extracted from the treated and untreated MCF7 cells was used as 
template to examine the expression level of six different genes (P53, Bcl2, TNF-α, IL-2, IL-6, and BCRA1). The gene 
GAPDH was employed as a housekeeping gene. The primers of these genes (Table1) were designed in this study using 
Primer3 design program (Koressaar and Remm, 2007; Untergasser et al., 2012) and using the available sequences for 
these genes in GenBank (Benson et al., 1999).  
The PCR reaction consisted of 10 μl of 2X i-MAX II Mix (Intron, Korea), 2 μl of the cDNA (50 ng/μl), 1μl of 
10 pM/μl of each primer (Table 1), 1 μl of 25mM MgCl2, and 5 μl of RNase free water in a total of 20 μl. Samples were 
spin before loading in the rotor’s wells. The PCR program was run as follows: initial denaturation at 95 °C for 5 min.; 
35 cycles of 95°C for 30 sec, annealing at 57°C for 30 sec and extension at 72 °C for 1.30 min, and final extension at 
72 °C for 10 min. The thermocycler, lifePro PCR System (BIOER, China) was used. The PCR products were visualized 
using 2% agarose gel electrophoresis and electrophoresis was carried out at 100 V for 1.5 h with 0.5X TBE buffer as 
running buffer with 7.5 l / 150 ml agarose gel RedSafe (Intron, Korea) nucleic acid staining solution. 
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Table 1: Oligo-nucleotide primer sequences designed in this study by Primer3 software  
Gene  Sequence accession 
No. 
 Primer sequence Annealing 
temperature (
o
C) 
Amplicon 
size (bp
a
) 
p53 AB082923.1 UM1F: 5'-GGCTCTGACTGTACCACCAT-3' 
UM1R: 5'-CACCTCAAAGCTGTTCCGTC-3' 
59.09 
59.13 
141 
Bcl2 
 
XM_006722523.1 UM2F: 5'-TTCTTTGAGTTCGGTGGGGT-3' 
UM2R: 5'-GCTGAAACTCCCTTAGCCCT-3' 
59.16 
59.38 
178 
TNF M26331.1 UM3F: 5'-GTCAACCTCCTCTCTGCCAT-3' 
UM3R: 5'-CCAAAGTAGACCTGCCCAGA-3' 
59.09 
59.02 
188 
IL-2 S77834.1 UM4F: 5'-AACTCACCAGGATGCTCACA-3' 
UM4R: 5'-TGCTGATTAAGTCCCTGGGT-3' 
58.94 
58.33 
159 
IL-6 JQ250825.1 UM5F: 5'-CCCTGACCCAACCACAAATG-3' 
UM5R: 5'-CTACATTTGCCGAAGAGCCC-3' 
59.03 
58.98 
142 
BRCA1 NM_007294.3 UM6F: 5'-TGCAGCATTTGAAAACCCCA-3' 
UM6R: 5'-TGGCGCTTTGAAACCTTGAA-3' 
58.87 
58.89 
186 
GAPDH NM_002046.5 UM7F: 5'-AGGTCGGAGTCAACGGATTT-3' 
UM7R: 5'-TGACGGTGCCATGGAATTTG-3' 
59.03 
59.11 
168 
a
bp: Base pair 
 
 
Results 
Antimicrobial Activity 
 
It was found that methanol and ethanol extracts of U. maritima fruits exhibited anticandidal activity and 
antibacterial activity against S. aureus and E. coli (Table 2). Whereas, aqueous and acetone extracts of U. maritima did 
not exhibit anticandidal activity but exhibited antibacterial activity against S. aureus and E. coli. 
 
Table 2: Antimicrobial activity of extracts from Urginea maritima against human pathogenic microorganisms  
Plant species 
Plant 
part 
Solvent 
Inhibition Zone (mm)
a
 
Staphylococcus aureus 
ATCC 25923 
Escherichia coli 
ATCC 25922 
Candida albicans 
ATCC 10231 
Urginea maritima Fruit Water 21.33±1.67 25.67±1.86 0 
Ethanol 18.00±1.15 20.33±1.20 0 
Methanol 18.33±0.67 19.33±1.20 14.67±1.67 
Acetone 28.67±2.58 17.00±0.58 15.67±0.88 
a
Inhibition zone diameters are expressed as Means±SE.  
 
Hemolytic and Anticancer Activities 
 
The crude extracts of U. maritima fruits were tested for their hemolytic activity against human erythrocytes 
(Table 3). It was found that ethanol and acetone extracts exhibited non-hemolytic activity. Whereas, Aqueous and 
methanol extracts exhibited α-hemolysis.  
Non-hemolytic U. maritima fruit extracts (ethanol and acetone extracts) was screened for their cytotoxicity 
against noncancerous MCF10A cells and breast cancer MCF7 cells (Table 3). The MTT assay was used to determine 
the degree of cytotoxicity of each crude extract. It was found that ethanol and acetone extracts of U. maritima exhibited 
selective cytotoxicity against breast cancer MCF7 cells (Table 3), killing MCF7 cells specifically. Both extracts 
exhibited low cytotoxicity on noncancerous MCF10A cells. Whereas, ethanol and acetone extracts produced high 
(+++) and very high (++++) cytotoxicities against cancerous MCF7 cells, respectively. 
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Table 3: Erythrocidal activity and selective cytotoxicity screening of non-hemolytic Urginea maritima fruit extracts 
against human noncancerous MCF10A cells and breast cancer MCF7 cells. 
Property Human cells 
Solvent 
Water Ethanol Methanol Acetone 
Type of Hemolysis
a
 Erythrocytes α γ α γ 
Cytotoxicity degree
b
 MCF10A - + (29.78) - + (22.01) 
 MCF7 - +++ (88.96) - ++++ (99.53) 
Selectivity
c
  - + - + 
a
Type of hemolysis: ; partial hemolysis, ; no hemolysis. bThe degree of cytotoxicity of nonhemolytic 
extracts was graded on the basis of the relative value of absorbance to the vehicle: ++++, very high (˂0.1); 
+++, high (0.1 to ˂0.4); ++, moderate (0.4 to ˂0.7); +, low (0.7 to ˂0.9); , very low (0.9 to ˂0.95); -, non-
toxic (0.95). The inhibition percentage was given in parentheses. cSelective cytotoxicity of a plant extract is 
when the plant crude extract has at most low cytotoxicity against MCF10A cells and has at least moderate 
cytotoxicity against breast cancer MCF7 cells. 
 
As shown in Table 4, the IC50 values for the non-hemolytic ethanol extract of U. maritima against breast 
cancer MCF7 cells was 11.01 µg/ml. Whereas, IC50 values for the non-hemolytic acetone extract of U. maritima against 
breast cancer MCF7 cells was 6.01 µg/ml. While, Doxorubicin drug (positive control) exhibited cytotoxic effect with 
higher IC50 value (52.35 µg/ml). 
 
Table 4: The median inhibitory concentration of non-hemolytic selectively cytotoxic Urginea maritima plant crude 
extracts against breast cancer MCF7 cells. 
Plant 
Plant 
part 
Solvent 
IC50
a
 
(µg/ml) 
R
2b
 Regression equation
c
 
Urginea maritima Fruit Ethanol 
Acetone 
11.01 
6.01 
0.93 
0.91 
y = 48.59ln(x) + 47.993 
y = 37.502ln(x) + 59.355 
Doxorubicin  - - 52.35 0.85 y = 48.562ln(x) + 23.692 
a
IC50: the median inhibitory concentration. 
b
R
2
: correlation coefficient. 
c
Y; inhibition percentage, X; 
inhibitory concentration at Y (X = ICY). 
DNA fragmentation 
 
DNA fragmentation assay was performed to detect DNA laddering (apoptotic feature) in MCF7 cells after 
treatment with U. maritima fruit extracts that exhibited selective cytotoxicity. As shown in Figure 1, DNA 
fragmentation was observed in MCF7 cells treated with non-hemolytic selectively cytotoxic ethanol and acetone 
extracts from U. maritima after 6 h and 24 h of incubation; the DNA patterns were consistent with nuclear 
fragmentation that occurs during apoptotic cell death. Furthermore, when comparing the DNA fragmentation results of 
MCF7 cells treated with U. maritima fruit extracts with the drug doxorubicin (positive control) and with negative 
control (untreated cells), U. maritima plant extracts tested in this study showed potential induction of apoptosis in 
breast cancer MCF7 cells (Figure 1). 
 
 
Figure 1: Agarose gel electrophoresis (1.2%) of DNA extracted from MCF7 cells treated with IC50 of non-hemolytic 
ethanol and acetone extracts of Urginea maritima fruits after 6 h and 24 h incubation. Marker; 1Kb molecular weight 
marker. Control; untreated MCF7 cells (negative control) after 6 h and 24 h. Doxorubicin; Doxorubicin treated cells 
(positive control) after 6 h and 24 h incubation. 
 80 
 
Gene expression 
 
The molecular mechanism induced by the most promising acetone extract of U. maritima fruits in inhibiting 
MCF7 breast cancer cells were investigated after treatment with equivalent volume to IC50 and to 4xIC50 concentrations 
for 6 h and 24 h. Analysis of gene expression of several apoptosis related genes (p53, Bcl2, TNF, and BRCA1) and 
immune response genes (IL-2 and IL-6) as well as the house keeping gene GAPDH was achieved by RT-PCR technique 
(Figure 2). 
Results presented in Figure 2A show the expression levels of different genes in treated cells with 1xIC50 and 
4xIC50 concentrations of U. maritima fruit acetone extract at 6 h and 24 h. In comparison to cells treated with 
Doxorubicin (Figure 2B) and the untreated cells (Figure 2C), the expression level of p53 increased in MCF7 cells 
subjected to acetone extract of U. maritima fruits and this expression induced with increasing the concentration of the 
extract and the incubation time (Figure 2A). Likewise, the expression of IL-2 gene was higher in extract-treated and 
Doxorubicin-treated cells, and the expression induced with increase of the concentration and the incubation time 
(Figure 2). The expression of IL-6 gene followed almost the same trend of IL-2 expression. Furthermore, BRCA1 gene 
was observed up-regulated in cells treated with 1xIC50 and 4xIC50 fruit extract at both incubation periods compared to 
negative control (Figure 2A and 2C). Likewise, the same result regarding the expression of BRCA1 gene was obtained 
when cells treated with Doxorubicin drug at 1xIC50 and 4xIC50 but with slightly lower expression level than that 
observed in treated cells with acetone extract of U. maritima (Figure 2B). Compared to the negative control, the 
expression of Bcl2 gene reduced in MCF7 cells treated with 1xIC50 acetone extract and in cells treated with 4xIC50 
Doxorubicin and this expression decreased as the incubation time increased (Figure 2). The expression of TNF gene 
increased after 6 h and almost the same with moderate expression level in the untreated control cells and cells treated 
with acetone extract (Figure 2A and 2C). The expression of TNF gene was higher in the cells treated with 1xIC50 and 
4xIC50 of Doxorubicin at 6 h compared to 24 h (Figure 2B). The expression level of the house keeping gene GADPH 
was showing the same trend in all treatments.  
 
 
 
Figure 2: RT-PCR analysis of the expression of p53, Bcl2, TNF, IL-2, IL-6, and BRCA1 genes as well as the house 
keeping GADPH gene in breast cancer MCF7 cells treated with 1xIC50 and 4xIC50 after 6 h and 24 h of incubation. A, 
Urginea maritima fruits acetone extract; B, Doxorubicin drug (positive control); C, Untreated breast cancer cells 
(negative control). 
 
Discussion 
 
Microbial resistance to conventional antibiotics has become a major healthcare problem (Alanis, 2005). There 
are considerable alternative sources of natural antimicrobials derived from medicinal plants with different mode of 
actions. Medicinal plants are rich in secondary metabolites of antimicrobial properties (Tiwari and Singh, 2004, Lewis 
and Ausubel, 2006). Many clinically useful antibiotics are derived from plants (Gilani and Atta-ur-Rahman, 2005). 
Therefore, there is an urgent need to discover new antimicrobial agents from unexplored plants which may produce 
secondary metabolites that can control serious bacterial and fungal infections. 
Cancer is the second cause of death in the world and in Jordan after cardiovascular diseases (Tarawneh et al., 
2010; WHO, 2012). Breast cancer is the second most common cancer in the world and the most frequent cancer among 
women (WHO, 2012). In Jordan, breast cancer was the most common among Jordanian females, with 36.5% of all 
cancers in women (Ministry of Health, Jordan Cancer Registry, 2013). Thus, there is an urgent need to explore natural 
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sources of anticancer agents such as plant secondary metabolites. Plants are used in the treatment of human diseases 
from earlier time. Therefore, a scientific interest for phytotherapy was increased in several medical fields including 
oncology. The use of plants in medicine has affected the identification of natural compounds for example cocaine, 
morphine, vinblastine, taxolo, and codeine (Balunas and Kinghorn, 2005). In this study, solid-liquid extraction was 
used to cover all range of phenolic compounds in U. maritima plant materials by using polar protic solvents (hot water, 
ethanol, and methanol) and polar aprotic solvent (acetone). 
It was found that aqueous, ethanol, methanol, and acetone extracts of U. maritima fruits exhibited high 
antibacterial activity against test bacteria (Gram-positive bacterium S. aureus and Gram-negative bacterium E. coli). 
Methanol and acetone extracts from fruits of U. maritima exhibited promising antifungal activity against C. albicans. 
This is the first report on antimicrobial activity of fruit extracts prepared from U. maritima. On the other hand, it has 
been reported that the bulbs extract of U. maritima has some potential antifungal activity (Khan and Abourashed, 2010) 
and the leaves extract exhibited moderate to low antifungal activity (Abou-Jawdah et al., 2004). 
The nonhemolytic U. maritima ethanol and acetone extracts screened for their selective cytotoxicity against 
noncancerous MCF10A and cancerous MCF7 cells. It was found that ethanol and acetone extracts of U. maritima fruit 
exhibited selective in vitro cytotoxicity against breast cancer cells by discrimination between cancer MCF7 cells and 
normal MCF10A cells, killing the former cells specifically. The U. maritima fruit ethanol and acetone extracts showed 
no hemolysis against human erythrocytes (Table 3). Thus, the anticancer activity in such plant extracts was not 
attributable to the induced hemolysis. Ethanol and acetone extracts of U. maritima fruits exhibited promising anticancer 
activity against breast cancer cells with the lowest IC50 value of acetone extract (6.01 µg/ml). According to the 
American National Cancer Institute (NCI), any crude extract possessing an IC50 less than 20 μg/ml is considered as 
active treatment against the tested cancer cells (Chen et al., 1988). Therefore, ethanol and acetone extracts of U. 
maritima fruits which had IC50 less than 20 μg/ml can be considered as an active treatment against breast cancer cells. 
This result may be related to the acute toxicity of this plant to target cancer cells (Mijatovic et al., 2007). This finding 
may lead to the use of these extracts for medicinal and pharmaceutical purposes including treatment of certain types of 
cancer specially breast cancer. There are no previous studies that demonstrate the potential anticancer activity for U. 
maritima fruit extracts. However, it was reported that the viability of neuroblastoma SH-SY5Y cells are selectively 
inhibited by aqueous extract of cardiotonic steroids from U. maritima bulb (Elghuol et al., 2016).  
In order to investigate whether apoptosis may have played a role in mediating the cell death of MCF7 cells 
after treatment with non-hemolytic U. maritima plant extracts, DNA fragmentation analysis of cells treated with the 
active extracts revealed that those extracts had a significant effect on the DNA when compared with the positive control 
Doxorubicin (Figure 1). This result suggests a possible induction of apoptosis after treatment of MCF7 cells with active 
plant extracts. Doxorubicin is an antibiotic with cytotoxic action which is conducted by inhibition of Topoisomerase II 
that act as DNA intercalator to prevent synthesis of nucleic acid and induce apoptosis (Wang et al., 2004). Interestingly, 
moderate DNA degradation in treated cells after 6 h and 24 h had been observed (Figure 1) compared with that in 
untreated cells (negative control) and Doxorubicin drug (positive control). Therefore, the DNA patterns produced in 
this study were similar to that presented by Gao et al. (2002) who reported that resveratrol from plant extract induced 
DNA fragmentation in 32Dp210 leukemic cells. On the other hand, the obtained DNA fragmentation result in this 
study is contrary to the finding of Tanih and Ndip (2013) who reported that apoptosis induction was detected by 
conversion of intense DNA band to faint band with no DNA fragmentation.  
It was reported that internucleosomal DNA fragmentation is not essential for apoptotic cell death, and that 
some necrotic cell death is accompanied by internucleosomal DNA fragmentation, suggesting the possibility that this 
fragmentation may not be sufficient as an indicator of apoptotic cell death (Cohen et al., 1992; Schulze-Osthoff et al., 
1994). Moreover, active induction of apoptosis in cancer cells when treated by plant extracts is an attractive way to 
cure many types of cancers. However, cancers have various strategies to escape from the recognition and elimination 
by the surveillance of host immune system. These strategies include altered expression of genes and proteins involved 
in cell survival and death (Croce, 2008). Among them, one of common survival strategy of cancer cells is to escape 
from apoptosis by deregulation of apoptotic genes, or hyper-activation of anti-apoptotic genes (Fesik, 2005). For these 
reasons, induction of apoptosis in breast cancer MCF7 cells by the most active U. maritima fruit extract (acetone 
extract) was evaluated in this study at molecular level by analysis of gene expression of several apoptosis related genes 
(p53, Bcl2, TNF, and BRCA1) and immune response genes (IL-2 and IL-6) as well as the house keeping gene GAPDH 
by RT-PCR technique to make sure that the mechanism of killing was occurred due to induction of apoptosis in MCF7 
cells. 
The expression level of the tumor suppressor gene p53 in cells treated with acetone extract of U. maritima 
fruits was observed and compared with the negative control (untreated cells) and with the positive control 
(Doxorubicin). Figure 2 illustrated that the expression of p53 was induced in MCF7 cancer cells treated with acetone 
extract. Under normal growth conditions, p53 is a short-lived protein and is expressed at low levels within the cell. In 
response to various cellular stresses, including exposure to DNA-damaging agents, irradiation, hypoxia, and nucleotide 
depletion, p53 is rapidly induced and functions as a transcriptional activator (Glaspy, 2002). In response to anticancer 
agents, damaged DNA triggers ATM kinase activity which catalyzes phosphorylation of p53 protein. Accumulation of 
phosphorylated p53 proteins in DNA-damaged cells activates two types of events cell cycle arrest and apoptosis 
induced (Jin et al., 2014). The p53 protein is a transcription factor that activates specific genes, including p21. The p21 
protein, a member of the Cdk inhibitor family, blocks activation of the Cdk-cyclin complex, leading to cell cycle arrest 
too. Furthermore, p21 protein activates gene-encoding proteins that trigger cell apoptotic processes through binding and 
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inactivation of Bcl2, an apoptotic inhibitor (Jin et al., 2014). Moreover, the results are consistent with Alshehri and 
Elsayed (2012) who found that p53 was induced after treatment of MCF7 cells with Cichorium endivia phenolic 
extract.   
The anti-apoptotic gene Bcl2 was down regulated in the treated cancer cells with both Doxorubicin and 
acetone extract of U. maritima fruits. The Bcl2 oncoprotein suppresses or delays the induction of apoptosis in prostate, 
skin, lymphoid tissues, and mammary gland (Yang et al., 2004). The obtained results are in agreement with that 
obtained by Alshehri and Elsayed (2012) who demonstrated reduction in expression of Bcl2 in MCF7 cells treated with 
C. endivia phenolic extracts. Down regulation of Bcl2 after treatment of MCF7 cells by Doxorubicin could be 
attributed to the fact that Doxorubicin up regulate the expression of Bax protein and down regulate the expression of 
antiapoptotic Bcl2 proteins (Leung and Wang, 1999). 
Treatment of MCF7 cells with acetone extract of U. maritima fruits and Doxorubicin drug lead to induction of 
expression of TNF gene after 6 h. However, the expression of TNF was reduced after 24 h (Figure 2). Recent studies 
(Szelényi, 2001; Brabers and Nottet, 2006) proved that the NF-κB factors, such as TNF, also serve as connecting links 
between inflammation and cancer. The TNF protein is released mainly from macrophages and regulates immune cells. 
Its dysregulation and overproduction lead to cancer and other diseases. The TNF protein also plays a role in the 
activation of NF-κB by binding to a TNF receptor present on the cell surface that in turn triggers a pathway that leads 
to the activation of apoptosis (Szelényi, 2001; Brabers and Nottet, 2006). Thus, the result of this study showed that 
apoptosis was induced at early stage (at 6 h) since TNF expression was reduced. 
The expression of IL-2 was so high in cells treated with U. maritima acetone extract and Doxorubicin when 
compared with that in the untreated control cells at 6 h and 24 h, in order (Figure 2). Interleukin-2 is a lymphokine that 
synthesized and secreted primarily by T helper lymphocytes that have been activated (Otsuki et al., 2010). Cytokines 
like IL-2 evaluated for possible use as immune stimulator in cancer patients, so IL-2 elicits as strong antitumor 
response in laboratory animals (Kleinsmith, 2006). At present, IL-2 is an approved treatment for advance cancers 
disease, such as advanced kidney cancer and melanoma (Kleinsmith, 2006). As well as, IL-2 is also being used 
experimentally to stimulate antitumor lymphocytes that are isolated from a patient’s tumor site and grown in the 
laboratory prior to being injected back into the bloodstream (Kleinsmith, 2006). Therefore, induced expression of IL-2 
in this study suggests an enhanced immune response against cancer. 
The expression of IL-6 was almost the same in cells treated with IC50 and 4xIC50 concentrations of U. maritima 
extracts and Doxorubicin. Interleukin 6 is an interleukin that react as both a pro-inflammatory cytokine and an anti-
inflammatory cytokine. In humans, IL-6 is secreted by T cells and macrophages to stimulate immune response, 
especially during infection and tissue damage leading to inflammation (Kleinsmith, 2006). The involvement of IL-6 in 
cancer has been quite controversial. It has two opposite faces in the tumor microenvironment; IL-6 has roles in both 
tumor-promoting and -suppressive activities by mobilizing T cell responses (Fisher et al., 2014). Therefore, the 
increased expression of IL-6 in MCF7 cells might function as an antitumor factor. 
Finally, BRCA1 tumor suppressor gene was up regulated in cells treated with U. maritima acetone extract 
(Figures 2). The same result was obtained when cells treated with Doxorubicin drug. Recent study (Roy et al., 2012) 
revealed that the protein encoded by this gene is involved in repairing DNA damage, especially double strand damage. 
The results of this study agreed with the obtained result by Bosviel et al. (2012) who showed that soy phytoestrogens 
increase the expression of BRCA1 tumor suppressor gene. 
 
Conclusions 
 
This is the first study to illustrate that fruit extracts of U. maritima exhibited antimicrobial and anticancer 
activities. Fruit extracts are considered to be a promising source of antimicrobials. The highest cytotoxicity against 
MCF7 cells was produced from acetone extract and possessed IC50 less than 20 μg/ml that can be considered as active 
treatment against breast cancer cells. Therefore, fruits of U. maritima are a hopeful source of biologically active 
metabolites that may be used in the development of future drugs for treatment of infectious diseases that caused by 
human bacterial and fungal pathogens as well as for treatment and/or improvement of current cancer therapies. Further 
studies concerning evaluation of in vivo cytotoxicity and determination of the chemical structure of the bioactive 
metabolites in fruit extracts are required to be used in medicinal and pharmaceutical applications. 
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